We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.01T
AUM Growth
+$82B
Cap. Flow
+$21.4B
Cap. Flow %
2.11%
Top 10 Hldgs %
17.99%
Holding
7,861
New
173
Increased
3,407
Reduced
3,131
Closed
203

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.06B
2
AMZN icon
Amazon
AMZN
+$1.51B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.42B
4
TSLA icon
Tesla
TSLA
+$1.17B
5
MSFT icon
Microsoft
MSFT
+$997M

Sector Composition

Rank Sector Weight
1 Technology 20.98%
2 Healthcare 10.48%
3 Financials 9.86%
4 Consumer Discretionary 8.78%
5 Industrials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILMW
6901
DELISTED
Lilium N.V. Warrants
LILMW
$2.65K ﹤0.01%
10,000
NVX
6902
NOVONIX
NVX
$99M
$2.63K ﹤0.01%
991
+841
+561% +$2.35K
BCDA icon
6903
BioCardia
BCDA
$12.3M
$2.63K ﹤0.01%
66
STRR
6904
DELISTED
Star Equity Holdings
STRR
$2.63K ﹤0.01%
500
SGMA
6905
DELISTED
Sigmatron International
SGMA
$2.56K ﹤0.01%
790
+400
+103% +$1.22K
IMPL
6906
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$2.54K ﹤0.01%
2,000
BIS icon
6907
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.32M
$2.52K ﹤0.01%
61
-15
-20% -$595
GTBP icon
6908
GT Biopharma
GTBP
$10.6M
$2.52K ﹤0.01%
269
GFAI icon
6909
Guardforce AI
GFAI
$9.69M
$2.5K ﹤0.01%
+495
New +$4.97K
UBT icon
6910
ProShares Ultra 20+ Year Treasury
UBT
$56.4M
$2.49K ﹤0.01%
100
BTWNU
6911
DELISTED
Bridgetown Holdings Limited Units
BTWNU
$2.48K ﹤0.01%
241
BNRG icon
6912
Brenmiller Energy
BNRG
$1.18M
$2.48K ﹤0.01%
+2
New +$3.74K
EET icon
6913
ProShares Ultra MSCI Emerging Markets
EET
$34.5M
$2.48K ﹤0.01%
49
TBJL icon
6914
Innovator 20+ Year Treasury Bond 9 Buffer ETF July
TBJL
$10.8M
$2.48K ﹤0.01%
120
FLZH
6915
Flash Sports & Media Holdings
FLZH
$63.2M
$2.48K ﹤0.01%
84
+4
+5% +$165
CRESW
6916
DELISTED
Cresud SACIF y A. Warrant
CRESW
$2.46K ﹤0.01%
4,480
SDPI
6917
DELISTED
Superior Drilling Products Inc.
SDPI
$2.46K ﹤0.01%
2,000
RINF icon
6918
ProShares Inflation Expectations ETF
RINF
$18.3M
$2.44K ﹤0.01%
75
CCEL icon
6919
Cryo-Cell International
CCEL
$27.6M
$2.43K ﹤0.01%
400
DARE icon
6920
Dare Bioscience
DARE
$18.3M
$2.41K ﹤0.01%
221
JFU
6921
9F Inc
JFU
$23.9M
$2.41K ﹤0.01%
810
SUSL icon
6922
iShares ESG MSCI USA Leaders ETF
SUSL
$1.14B
$2.4K ﹤0.01%
31
-29
-48% -$2.12K
WLMS
6923
DELISTED
Williams Industrial Services Group Inc.
WLMS
$2.39K ﹤0.01%
6,284
-683
-10% -$478
TLPH icon
6924
Talphera
TLPH
$66.4M
$2.38K ﹤0.01%
2,142
-236
-10% -$206
UTRS
6925
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$2.37K ﹤0.01%
462

Similar funds

Morgan Stanley's Q2 2023 Portfolio in Review

As of Q2 2023, Morgan Stanley held 7,861 positions worth $1.01T, up 8.8% from $933B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.8%. Morgan Stanley opened 173 new positions and exited 203, leaving the 7,861-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 3,490,516 shares worth $87.1M.
  • Morgan Stanley added most to NVIDIA in Q2 2023, an estimated $2.06B increase.
  • Morgan Stanley's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $724M.
  • Morgan Stanley fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $925M.
  • Morgan Stanley's ten largest holdings make up 18% of its $1.01T portfolio in Q2 2023.
  • Morgan Stanley opened 173 new positions and closed 203 in Q2 2023.
  • Morgan Stanley's portfolio value rose 8.8% quarter-over-quarter to $1.01T.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.